Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 864-871

  Jung, Thomas ^a,c   Wagner, Kathrin ^b   Neumann, Christine ^a   Hausser, Christoph H ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NOVARTIS RESEARCH INSTITUTE   (Austria)

Author keywords

Human; IL 4; Soluble IL 4 receptor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0033024881     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199903)29:03<864::aid-immu864>3.0.co;2-t     Document Type: Article

References (41)

1. Mosmann, T. R. and Coffman, R. L., Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
2. Bradding, P., Feather, I. H., Howarth, P. H., Mueller, R., Roberts, J. A., Britten, K., Bews, J. P. A., Hunt, X., Okayama, Y., Heusser, C. H., Bullock, G. R., Church, M. K. and Holgate, S. T., Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 1992. 176: 1381-1393.
3. Brunner, T., Heusser, Ch. and Dahinden, C. A., Human peripheral blood basophils primed by IL-3 produce IL-4 in response to IgE receptor stimulation. J. Exp. Med. 1993. 177: 605-614.
4. Park, L. S., Friend, D., Sassenfeld, H. M. and Urdal, D. L., Characterization of the human B cell stimulatory factor 1 receptor. J. Exp. Med. 1987. 166: 476-488.
5. Idzerda, R. L., March, C. J., Mosley, B., Lyman, S. D., Bos, T. V., Gimpel, S. D., Din, W. S., Grabstein, K. H., Widmer, M. B., Park, L. S., Cosman, D. and Beckmann, M. P., Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 1990. 171: 861-873.
6. Russell, S. M., Keegan, A. D., Harada, N. et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 1993. 262: 1880-1883.
7. Sager, N., Feldmann, A., Schilling, G., Kreitsch, P. and Neumann, C., House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J. Allergy Clin. Immunol. 1992. 89: 801-810.
8. van der Heijden, F. L., Wierenga, E. A., Bos, J. D. and Kapsenberg, M. L., High frequency of IL-4 producing CD4 allergen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Dermatol. 1991. 97: 389-394.
9. Durham, S. R., Ying, S., Varney, V. A., Jacobson, M. R., Sudderick, R. M., Mackay, I. S., Kay, A. B. and Hamid, Q. A., Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 1992. 148: 2390-2394.
10. Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R. and Kay, A. B., Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992. 326: 298-304.
11. Robinson, D., Hamid, Q., Bentley, A., Ying, S., Kay, A. B. and Durham, S. R., Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 1993. 92: 313-324.
12. Coffman, R. L., Varkila, K., Scott, P. and Chatelain, R., Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol. Rev. 1991. 123: 189-207.
13. Wu, C. Y., Demeure, C. E., Gately, M., Podlaski, F., Yssel, H., Kiniwa, M. and Delespesse, G., In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 1994. 152: 1141-1153.
14. Demeure, C. E., Wu, C. Y., Shu, U., Schneider, P. V., Hausser, C., Yssel, H. and Delespesse, G., In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J. Immunol. 1994. 152: 4775-4782.
15. Coyle, A. J., Le Gros, G., Bertrand, C., Tsuyuki, S., Heusser, C. H., Kopf, M. and Anderson, G. P., Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am. J. Respir. Cell Mol. Biol. 1995. 13. 54-59.
16. Garrone, P., Djossou, O., Galizzi, J. P. and Banchereau, J., A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur. J. Immunol. 1991. 21: 1365-1369.
17. Enssle, K., Enders, B., Kurrle, R., Lauffer, L., Schorlemmer, H. U., Dickneite, G., Kanzy, E. J. and Seiler, F. R., Biology of natural and recombinant soluble interleukin-4 receptor. Behring. Inst. Mitt. 1995. 96. 103-117.
18. Renz, H., Enssle, K., Lauffer, L., Kurrle, R. and Gelfand, E. W., Inhibiton of allergen-induced IgE and IgG1 production by soluble IL-4 receptor. Int. Arch. Allergy Immunol. 1995. 106: 46-54.
19. Gessner, A., Schroppel, K., Will, A., Enssle, K. H., Lauffer, L. and Röllinghoff, M., Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis. Infect. Immun. 1994. 62: 4112-4117.
20. Puccetti, P., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Enssle, K. H., Romani, L. and Bistoni, F., Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis. 1994. 169: 1325-1331.
21. Fernandez Botran, R. and Vitetta, E. S., Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J. Exp. Med. 1991. 174: 673-681.
22. Sato, T. A., Widmer, M. B., Finkelman, F. D., Madani, H., Jacobs, C. A., Grabstein, K. H. and Maliszewski, C. R., Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 1993. 150: 2717-2723.
23. Maliszewski, C. R., Sato, T. A., Davison, B., Jacobs, C. A., Finkelman, F. D. and Fanslow, W. C., In vivo biological effects of recombinant soluble interleukin-4 receptor. Proc. Soc. Exp. Biol. Med. 1994. 206: 233-237.
24. Finkelman, F. D., Maden, K. B., Morri, S. C., Holmes, J. M., Boiani, N., Katona, I. M. and Maliszewski, C. R., Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol. 1993. 151: 1235-1244.
25. Jung, T., Bews, J. P. A., Enssle, K. H., Wagner, K., Neumann, C. and Heusser, C. H., Detection of and discrimination between total and free human interleukin-4 and free soluble interleukin-4 receptor by ELISA. J. Immunol. Methods 1998. 27: 41-50.
26. Jacobs, C. A., Lynch, D. H., Roux, E. R., Miller, R., Davis, B., Widmer, M. B., Wignall, J., VandenBos, T., Park, L. S. and Beckmann, M. P., Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptor. Blood 1991. 77: 2396-2403.
27. Renz, H., Bradley, K., Enssle, K., Loader, J. E., Larsen, G. L. and Gelfand, E. W., Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int. Arch. Allergy Immunol. 1996. 109: 167-176.
28. Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H. and Rose-John, S., The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 1996. 183: 1399-1406.
29. Ma, Y., Hurst, H. E. and Fernandez Botran, R., Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4. J. Pharmacol. Exp. Ther. 1996. 279: 340-350.
30. Fernandez Botran, R., Chilton, P. M. and Ma, Y., Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. Adv. Immunol. 1996. 63: 269-336.
31. Fisher, C. J., Jr., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. and Benjamin, E. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N. Engl. J. Med. 1996. 334: 1697-1702.
32. Jung, T., Schauer, U., Rieger, C., Wagner, K., Einsle, K., Neumann, C. and Heusser, C., Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Eur. J. Immunol. 1995. 25: 2413-2416.
33. Jung, T., Wijdenes, J., Neumann, C., de Vries, J. E. and Yssel, H., Interleukin-13 is produced by activated human CD45RA+ and CD45R0+ T cells. Modulation by interleukin-4 and interleukin-12. Eur. J. Immunol. 1996. 26: 571-577.
34. Fernandez Botran, R., Wynn, T. A., Hieny, S., Caspar, P., Chilton, P. M. and Sher, A., Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis. Eur. J. Immunol. 1995. 25: 649-656.
35. Chilton, P. M. and Fernandez Botran, R., Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. J. Immunol. 1993. 151: 5907-5917.
36. Blum, H., Wolf, M., Enssle, K., Röllinghoff, M. and Gessner, A., Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. J. Immunol. 1996. 157: 1846-1853.
37. Schauer, U., Schmitt, M., Müller, S., Enssle, K., Kurrle, R., Sundermann, U., Bender, A., Wahn, U. and Rieger, C. H. L., Soluble interleukin-4 receptor in atopic children. Int. Arch. Allergy Immunol. 1995. 108: 175-182.
38. Jung, T., Schauer, U., Heusser, C., Neumann, C. and Rieger, C., Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 1993. 159: 197-207.
39. Enssle, K. and Schulz, G., Regulation of interleukin-4 activity by soluble interleukin-4 receptors. J. Clin. Lab. Anal. 1995. 9: 450-455.
40. Brinkmann, V., Geiger, T., Alkan, S. and Heusser, C. H., Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J. Exp. Med. 1993. 178: 1655-1663.
41. Hu Li, J., Ohara, J., Watson, C., Tsang, W. and Paul, W. E., Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 1989. 142: 800-807.